Dipeptidyl Peptidase-4 Inhibitor (DPP4i) for the Control of Hyperglycemia in Patients With COVID-19

NCT04542213 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

70

Enrollment

OTHER

Sponsor class

Conditions

Hyperglycemia
Covid19

Interventions

DRUG: Linagliptin tablet
DRUG: Insulin

Sponsor

Hospital Regional de Alta Especialidad del Bajio